Education
About Us
Working with TipRanks
Follow Us
Roche Holding Ltd (CH:RO)
:RO
RO Stock Chart & Stats
Day’s Range― - ―
52-Week RangeCHF244.00 - CHF333.60
Previous CloseN/A
Volume5.14K
Average Volume (3M)22.13K
Market Cap
CHF198.44B
Enterprise ValueCHF246.20B
Total Cash (Recent Filing)CHF17.32B
Total Debt (Recent Filing)CHF36.35B
Price to Earnings (P/E)21.8
Beta1.21
Next Earnings
Jan 29, 2026EPS Estimate
9.27Last Dividend Ex-Date
Mar 27, 2025Dividend Yield3.76%
Share Statistics
EPS (TTM)11.08
Shares Outstanding106,691,000
10 Day Avg. Volume30,370
30 Day Avg. Volume22,132
Financial Highlights & Ratios
PEG Ratio-0.88
Price to Book (P/B)6.41
Price to Sales (P/S)3.26
P/FCF Ratio13.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Roche Holding Ltd News
RO FAQ
What was Roche Holding Ltd’s price range in the past 12 months?
Roche Holding Ltd lowest stock price was CHF244.00 and its highest was CHF333.60 in the past 12 months.
What is Roche Holding Ltd’s market cap?
Roche Holding Ltd’s market cap is CHF198.44B.
When is Roche Holding Ltd’s upcoming earnings report date?
Roche Holding Ltd’s upcoming earnings report date is Jan 29, 2026 which is in 171 days.
How were Roche Holding Ltd’s earnings last quarter?
Roche Holding Ltd released its earnings results on Jul 24, 2025. The company reported CHF11.08 earnings per share for the quarter, beating the consensus estimate of CHF10.77 by CHF0.31.
Is Roche Holding Ltd overvalued?
According to Wall Street analysts Roche Holding Ltd’s price is currently Overvalued.
Does Roche Holding Ltd pay dividends?
Roche Holding Ltd pays a Annually dividend of CHF9.7 which represents an annual dividend yield of 3.76%. See more information on Roche Holding Ltd dividends here
What is Roche Holding Ltd’s EPS estimate?
Roche Holding Ltd’s EPS estimate is 9.27.
How many shares outstanding does Roche Holding Ltd have?
Roche Holding Ltd has 106,691,000 shares outstanding.
What happened to Roche Holding Ltd’s price movement after its last earnings report?
Roche Holding Ltd reported an EPS of CHF11.08 in its last earnings report, beating expectations of CHF10.77. Following the earnings report the stock price went up 1.227%.
Which hedge fund is a major shareholder of Roche Holding Ltd?
Currently, no hedge funds are holding shares in CH:RO
Company Description
Roche Holding Ltd
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Technical Analysis
Ownership Overview
―
Insiders
1.42%
Mutual Funds
<0.01% Other Institutional Investors
94.44% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---